The Alliance for Regenerative Medicine (ARM) is hosting a webinar on Commercialization Strategies for cell and gene therapies, sponsored by Catalent. This session will focus on the commercialization strategies essential for bringing cell and gene therapies to market. Expert speakers, including Robert Allen, Ph.D., and Sarah Creviston, will discuss navigating regulatory challenges, securing funding, scaling manufacturing, and achieving market access. 

Attendees from biotechnology and beyond are encouraged to attend to gain valuable insights into overcoming obstacles and capitalizing on opportunities in the regenerative medicine sector.

The event will take place on November 20, 2024, from 11 AM to 12 PM EST.. To learn more about the event and register, click here.